PA
Probity Advisors’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
13,516
-390
| -3% | -$43.2K | 0.26% | 67 |
|
|
2025
Q1 | $1.56M | Sell |
13,906
-545
| -4% | -$61.1K | 0.3% | 63 |
|
|
2024
Q4 | $1.33M | Sell |
14,451
-751
| -5% | -$69.4K | 0.26% | 66 |
|
|
2024
Q3 | $1.27M | Buy |
15,202
+1,496
| +11% | +$125K | 0.24% | 76 |
|
|
2024
Q2 | $940K | Buy |
13,706
+2,222
| +19% | +$152K | 0.19% | 95 |
|
|
2024
Q1 | $841K | Sell |
11,484
-171
| -1% | -$12.5K | 0.17% | 104 |
|
|
2023
Q4 | $944K | Buy |
11,655
+1,387
| +14% | +$112K | 0.21% | 96 |
|
|
2023
Q3 | $769K | Buy |
10,268
+775
| +8% | +$58.1K | 0.18% | 86 |
|
|
2023
Q2 | $732K | Buy |
+9,493
| New | +$732K | 0.16% | 93 |
|
|
2022
Q4 | $775K | Sell |
9,026
-222
| -2% | -$19.1K | 0.18% | 87 |
|
|
2022
Q3 | $571K | Sell |
9,248
-1,372
| -13% | -$84.7K | 0.14% | 96 |
|
|
2022
Q2 | $656K | Buy |
10,620
+183
| +2% | +$11.3K | 0.15% | 95 |
|
|
2022
Q1 | $620K | Sell |
10,437
-156
| -1% | -$9.27K | 0.13% | 110 |
|
|
2021
Q4 | $769K | Buy |
10,593
+507
| +5% | +$36.8K | 0.15% | 108 |
|
|
2021
Q3 | $705K | Buy |
10,086
+696
| +7% | +$48.7K | 0.15% | 109 |
|
|
2021
Q2 | $647K | Buy |
9,390
+1,477
| +19% | +$102K | 0.14% | 117 |
|
|
2021
Q1 | $511K | Buy |
+7,913
| New | +$511K | 0.11% | 125 |
|
|
2020
Q3 | $309K | Buy |
4,894
+972
| +25% | +$61.4K | 0.09% | 144 |
|
|
2020
Q2 | $302K | Buy |
+3,922
| New | +$302K | 0.09% | 147 |
|